Rongfeng Liu

PTEN/AKT upregulation of TMSB10 contributes to lung cancer cell growth and predicts poor survival of the patients.

N. Zhou, Jie Li, Shao-hui Zhou, 2020, Bioscience, biotechnology, and biochemistry.

Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report

Zhiguo Zhou, C. Pan, Yibing Liu, 2022, Anti-cancer drugs.

Effect of Conventional Nursing Combined with Bedtime Oculomotor Training on Sleep Quality and Body Immunity of Advanced Lung Cancer Patients

Ling Chen, Rongfeng Liu, Haiping Hu, 2022, Journal of healthcare engineering.

Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis.

Zhi-yu Wang, Jie Shen, Zheng Wu, 2015, Oncology letters.

Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis

Z. Tian, Zhenhua Li, Huilai Lv, 2021, OncoTargets and therapy.

[MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].

Zhihong Xu, Yanzhi Cui, Lingling Zhang, 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma

X. Duan, M. Yuan, Jian Shi, 2023, Experimental and therapeutic medicine.

Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer

Ziwei Yang, S. Ding, Rongfeng Liu, 2019 .

The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma

Yanzhao Xu, Rongfeng Liu, Ruigang Dou, 2024, Open medicine.